title: [Selected aspects of oral contraception side effects].
abstract: The first hormonal pill was approved in the 60s of the twentieth century Since that time, oral contraception has been used worldwide by dozens of women due to its high availability as well as relative ease and safety of taking. The main side effects of oral contraception include elevated risk for venous thromboembolism (VTE). Estrogens increase the probability of VTE development, depending on the dose in medication, and third-generation progestins increase the risk of VTE development more than older-generation progestins. Also, the coexistence of hereditary thrombophilia increases the risk of VTE development in women using oral contraceptives. Other side effects include changes in the carbohydrate and lipid economy Progestins in oral contraceptives decrease HDL cholesterol levels but increase LDL cholesterol and total cholesterol levels. Additionally estrogens are a recognized mitogenic factor for the epithelium of the mammary gland, acting proliferative on the glandular tissue and in the same way influence on the increased risk of breast cancer development. Patients sometimes complain about some subjective side symptoms such as headache, mood changes, nausea, back pain, breast pain and swelling, as well as decreased libido. Some patients discontinue oral contraception due to fear of side effects or temporary ailments before con- sulting their doctor what may result in unintended pregnancy The aim of the following paper was to present most frequent side effects of oral contraception, ways of their moni- toring and diagnosis.
authors: Hubert
authors: H
authors: Wolski
mesh_terms: D001416:Back Pain / Q000139:chemically induced; D008076:Cholesterol, HDL / Q000187:drug effects; D003278:Contraceptives, Oral, Hormonal / Q000008:administration & dosage / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006261:Headache / Q000139:chemically induced; D006293:Health Promotion / Q000458:organization & administration*; D006801:Humans; D059373:Mastodynia / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D011372:Progestins / Q000009:adverse effects; D018570:Risk Assessment / Q000379:methods; D054556:Venous Thromboembolism / Q000139:chemically induced* / Q000517:prevention & control; D016387:Women's Health
chemical_list: D008076:Cholesterol, HDL; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D011372:Progestins; D004997:Ethinyl Estradiol